Stay updated on Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial

Sign up to get notified when there's something new on the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Added a government operations notice and a version upgrade to v3.2.0; removed the v3.1.0 tag.
    Difference
    13%
    Check dated 2025-10-04T16:57:17.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; core content and other critical elements remain unchanged.
    Difference
    0.3%
    Check dated 2025-09-27T13:40:04.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    There are no significant changes to the page content. The only update is the revision tag changed from v3.0.1 to v3.0.2.
    Difference
    0.3%
    Check dated 2025-09-13T02:42:18.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.3%
    Check dated 2025-09-05T20:01:50.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while several location-related terms and the previous revision number have been removed.
    Difference
    4%
    Check dated 2025-08-29T19:03:10.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-15T12:49:36.000Z thumbnail image

Stay in the know with updates to Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page.